Lansdowne Partners (UK)’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Lansdowne Partners (UK)’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-722,354	Closed	-$7.16M	–	61
2016 Q1	$7.16M	Hold	722,354	–	–	0.06%	22
2015 Q4	$8.31M	Hold	722,354	–	–	0.06%	26
2015 Q3	$9.75M	Hold	722,354	–	–	0.08%	20
2015 Q2	$10M	Hold	722,354	–	–	0.09%	21
2015 Q1	$10.2M	Buy	722,354 +200,000	+38%	+$2.72M	0.09%	24
2014 Q4	$7.11M	Hold	522,354	–	–	0.06%	31
2014 Q3	$7.98M	Hold	522,354	–	–	0.07%	32
2014 Q2	$8.79M	Buy	+522,354	New	+$9.4M	0.08%	31

Other funds holding OXFD

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Lansdowne Partners (UK)'s OXFD Position: Q2 2016 in Review

Lansdowne Partners (UK) sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2016, closing a stake of 722,354 shares — an estimated $7.16M sold.

Lansdowne Partners (UK) first reported a position in OXFD in Q2 2014 and held it in 8 quarters. The position peaked at $10.2M in Q1 2015. 56 funds tracked by Wall St. Rank hold OXFD as of Q2 2016.

Lansdowne Partners (UK) reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2016 after selling out during the quarter.
Lansdowne Partners (UK) sold 722,354 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2016, an estimated $7.16M.
Lansdowne Partners (UK) first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2014 and held it in 8 quarters.
Lansdowne Partners (UK)'s Oxford Immunotec Global PLC Ordinary Shares position peaked at $10.2M in Q1 2015.
56 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2016.

Based on Lansdowne Partners (UK)'s 13F filing for Q2 2016, filed 15 Aug 2016.